{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-007077","form_type":"8-K","ticker":"ACRV","cik":"0001781174","company_name":"Acrivon Therapeutics, Inc.","filed_at":"2026-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.152378+00:00","generated_at":"2026-05-16T11:14:33.628817+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Acrivon Therapeutics Provides Clinical Data Updates for ACR-368 and Initial ACR-2316 Data","bullets":["On January 8, 2026, Acrivon hosted a webcast and conference call featuring ACR-368 clinical data and program updates.","Initial clinical data for ACR-2316 were presented during the webcast.","The presentation was posted on the company website at ir.acrivon.com under Investors & Media.","Exhibit 99.1 to the 8-K filing contains the January 8, 2026 Data Update."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-007077","json":"https://secwatch.observer/filing/0001193125-26-007077.json","markdown":"https://secwatch.observer/filing/0001193125-26-007077.md","text":"https://secwatch.observer/filing/0001193125-26-007077.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1781174/000119312526007077/0001193125-26-007077-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1781174/000119312526007077/acrv-20260108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-16T11:14:33.628817+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}